We examined the methylation levels of the four genes in human AML samples and observed significant hypermethylation compared to healthy granulocytes and CD34+ cells in HES6, ITPKA and TAL1, while BCOR showed a trend towards hypermethylation in a subgroup of AML patients (Figure 5). This evidence concerns the gene TAL1 and acute myeloid leukemia.